Matches in Wikidata for { <http://www.wikidata.org/entity/Q60050336> ?p ?o ?g. }
Showing items 1 to 70 of
70
with 100 items per page.
- Q60050336 description "im September 2014 veröffentlichter wissenschaftlicher Artikel" @default.
- Q60050336 description "scholarly article by M. Canadell et al published 1 September 2014 in Journal of Neurology, Neurosurgery and Psychiatry" @default.
- Q60050336 description "wetenschappelijk artikel" @default.
- Q60050336 description "наукова стаття, опублікована у вересні 2014" @default.
- Q60050336 name "M17 Targeting Dopamine D1-histamine H3 Receptor Heteromers As A Therapeutical Strategy To Prevent Cognitive Deficits And Neurodegeneration In Huntington's Disease" @default.
- Q60050336 name "M17 Targeting Dopamine D1-histamine H3 Receptor Heteromers As A Therapeutical Strategy To Prevent Cognitive Deficits And Neurodegeneration In Huntington's Disease" @default.
- Q60050336 type Item @default.
- Q60050336 label "M17 Targeting Dopamine D1-histamine H3 Receptor Heteromers As A Therapeutical Strategy To Prevent Cognitive Deficits And Neurodegeneration In Huntington's Disease" @default.
- Q60050336 label "M17 Targeting Dopamine D1-histamine H3 Receptor Heteromers As A Therapeutical Strategy To Prevent Cognitive Deficits And Neurodegeneration In Huntington's Disease" @default.
- Q60050336 prefLabel "M17 Targeting Dopamine D1-histamine H3 Receptor Heteromers As A Therapeutical Strategy To Prevent Cognitive Deficits And Neurodegeneration In Huntington's Disease" @default.
- Q60050336 prefLabel "M17 Targeting Dopamine D1-histamine H3 Receptor Heteromers As A Therapeutical Strategy To Prevent Cognitive Deficits And Neurodegeneration In Huntington's Disease" @default.
- Q60050336 P1433 Q60050336-B97E9CCC-505B-4E87-92DC-C77FD87ED309 @default.
- Q60050336 P1476 Q60050336-EC7736BC-776D-4E8E-8452-BC00D666B709 @default.
- Q60050336 P2093 Q60050336-0F8BF50C-9F78-42D5-BD57-6C538FA19BB1 @default.
- Q60050336 P2093 Q60050336-14E1B196-AAA4-429E-93AD-FD6000FE5697 @default.
- Q60050336 P2093 Q60050336-19A780CB-B909-4AAC-90BB-4F3C953C572C @default.
- Q60050336 P2093 Q60050336-1DED8F1C-56B5-4AB0-99CD-7E44A51D4ED6 @default.
- Q60050336 P2093 Q60050336-2CA65E8D-2689-4F94-B0D5-B2F1F44822FA @default.
- Q60050336 P2093 Q60050336-3009EFD1-003B-47A2-8C75-08EEA761450F @default.
- Q60050336 P2093 Q60050336-5DDFA545-D58C-4D0B-940B-C0FF7551AB52 @default.
- Q60050336 P2093 Q60050336-78211765-BD24-4BE4-BD16-14B6C9998DE7 @default.
- Q60050336 P2093 Q60050336-8E440C43-BB84-4FB7-A71B-12E1001A604F @default.
- Q60050336 P2093 Q60050336-90E0105E-1423-41A5-9398-D5FB44D33920 @default.
- Q60050336 P2093 Q60050336-B23DBFDB-33F2-4364-9823-7EC44A8CE1C1 @default.
- Q60050336 P2093 Q60050336-B45B7AE0-5C05-4325-AF2E-A1C0DC030795 @default.
- Q60050336 P2093 Q60050336-C5A1DF7C-66CC-40FC-BEFE-88BFA33510C4 @default.
- Q60050336 P2093 Q60050336-CC7BEE44-8C15-4035-A95B-DB0855E07418 @default.
- Q60050336 P2093 Q60050336-CFDEA8D6-E632-4268-9A5B-AABC7885AF22 @default.
- Q60050336 P2093 Q60050336-D7DA795E-7765-4DE1-AAC8-F36A7A2561A4 @default.
- Q60050336 P2093 Q60050336-F90EBABB-233D-4238-9C3E-954A6C037299 @default.
- Q60050336 P2093 Q60050336-FA53FA01-089F-46D0-8A76-E83EEA822CE7 @default.
- Q60050336 P304 Q60050336-E21B9026-C296-404C-BA00-7197772A4C76 @default.
- Q60050336 P31 Q60050336-949DDE9E-2D42-4483-8C44-923682630049 @default.
- Q60050336 P356 Q60050336-C8DEEDDC-68D1-4B55-B5FA-21F13055837B @default.
- Q60050336 P407 Q60050336-FE5F23A1-0A26-465F-A0A8-598A3809E6EF @default.
- Q60050336 P433 Q60050336-AC18E63E-2B46-4DF6-A839-B1E96671155F @default.
- Q60050336 P478 Q60050336-3ED71CA0-C10D-4A1E-ABAC-F94627D8B393 @default.
- Q60050336 P577 Q60050336-49BF1A7E-49DB-42E4-A07C-9969AB367709 @default.
- Q60050336 P921 Q60050336-8c183e4a-ba7b-4a4d-a485-e5486ab3bf2b @default.
- Q60050336 P921 Q60050336-A0425CC5-D133-45D3-8972-19447F2EF259 @default.
- Q60050336 P356 JNNP-2014-309032.289 @default.
- Q60050336 P1433 Q1599804 @default.
- Q60050336 P1476 "M17 Targeting Dopamine D1-histamine H3 Receptor Heteromers As A Therapeutical Strategy To Prevent Cognitive Deficits And Neurodegeneration In Huntington's Disease" @default.
- Q60050336 P2093 "A. Cordomi" @default.
- Q60050336 P2093 "C. Lluis" @default.
- Q60050336 P2093 "D. Moreno-Delgado" @default.
- Q60050336 P2093 "E. Canela" @default.
- Q60050336 P2093 "E. Moreno" @default.
- Q60050336 P2093 "G. Navarro" @default.
- Q60050336 P2093 "J. Alberch" @default.
- Q60050336 P2093 "J. Botta" @default.
- Q60050336 P2093 "L. Howell" @default.
- Q60050336 P2093 "L. Pardo" @default.
- Q60050336 P2093 "M. Canadell" @default.
- Q60050336 P2093 "M. Guzman" @default.
- Q60050336 P2093 "M. Rodriguez-Ruiz" @default.
- Q60050336 P2093 "P. Gasperini" @default.
- Q60050336 P2093 "P. J. McCormick" @default.
- Q60050336 P2093 "S. Ferre" @default.
- Q60050336 P2093 "S. Gines" @default.
- Q60050336 P2093 "V. Casado" @default.
- Q60050336 P304 "A100-A100" @default.
- Q60050336 P31 Q13442814 @default.
- Q60050336 P356 "10.1136/JNNP-2014-309032.289" @default.
- Q60050336 P407 Q1860 @default.
- Q60050336 P433 "Suppl 1" @default.
- Q60050336 P478 "85" @default.
- Q60050336 P577 "2014-09-01T00:00:00Z" @default.
- Q60050336 P921 Q170304 @default.
- Q60050336 P921 Q190564 @default.